RxDoctor Payments Data

Steven Frank, DPM

Foot & Ankle Surgery · Saint Louis, MONPI 1437115979

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (40.8%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Elite Orthopedics, LLC at 41.6% of the total. Reporting peaked in 2019 at $5,039 and has fallen 79.4% since, to $1,039 in 2025.

$17,214in general payments, 2019–2025

Across 169 payments — averaging $101.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Elite Orthopedics, LLC$7K
  • Arthrex$4K
  • Stryker$3K
  • Smith+Nephew$785
  • Kerecis Limited$545
  • KCI USA, Inc.$155
  • plus $795 from 14 others

What the payments were for

  • Speaking & faculty fees$3,00017%
  • Travel & lodging$8575%
  • Food & beverage$6,33037%
  • Education$7,02741%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,214 in reported general payments places this provider in the 75th percentile of 163 foot & ankle surgery providers in Missouri.

See all foot & ankle surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$249,137
Medicare patients
471
Services billed
2,730

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tavaborole19$6,267
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort30$1,699
Mupirocin82$659
Lidocaine12$611
Cephalexin52$384
Gabapentin21$210
Terbinafine Hcl19$179
Ammonium Lactate16$169
Pregabalin15$92
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen19$85

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →